跳至主要内容
临床试验/NCT02235571
NCT02235571已完成不适用

iChoose Kidney Decision Aid for Treatment Options Among End-Stage Renal Disease (ESRD) Patients

Emory University4 个研究点 分布在 1 个国家目标入组 470 人开始时间: 2014年9月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
470
试验地点
4
主要终点
Effectiveness of the iChoose Kidney intervention to improve knowledge and shared decision-making between patients and physicians regarding ESRD treatment options.

研究概览

简要总结

The investigators developed iChoose Kidney -- a shared decision-making support tool accessible through iPad, iPhone, or the web -- to provide ESRD patients and their providers with a simple, standardized, easily accessible, statistically robust tool for use in the clinic to guide patient education and healthcare decision-making about treatment options of dialysis or kidney transplantation. The iChoose Kidney decision aid provides patients with estimates of their individualized 1 and 3-year risks of mortality on dialysis vs. transplantation, based on previous national data. The tool has the potential to improve communication and decision-making between patients and their healthcare providers and improve access to kidney transplantation among patients with ESRD.

This will be a two-arm, randomized study, and will be conducted at 3 large transplant centers with diverse patient populations. One group of patients will receive standard education alone during their scheduled transplant evaluation. The second group will receive the standard education as well have the provider use the iChoose Kidney aid with them. The project timeline will be a total of 24 months inclusive of enrollment, follow-up, data analysis, and outcome evaluation.

This study will assess how well the iChoose decision aid works in improving patient knowledge, preferences for treatment, and patient access to transplant. The study will also assess whether providers find the tool useful for providing ways to share information with patients about ways to treat their kidney disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of end-stage renal disease (ESRD) and on dialysis for < 1 year
  • English-speaking
  • Subjects coming in for transplant medical evaluation
  • Age > 18 years

排除标准

  • Severe cognitive or visual impairment

研究组 & 干预措施

Control

No Intervention

These subjects are receiving standard patient education

iChoose Kidney Decision Aid

Experimental

These subjects receive iChoose Kidney Decision Aid along with standard patient education

干预措施: iChoose Kidney Decision Aid (Behavioral)

结局指标

主要结局

Effectiveness of the iChoose Kidney intervention to improve knowledge and shared decision-making between patients and physicians regarding ESRD treatment options.

时间窗: Up to 19 months

Patient knowledge of the survival benefit of transplant and the patient's individualized mortality risk

次要结局

  • Patient access to transplant(Up to 19 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rachel Patzer, PhD

Assistant Professor

Emory University

研究点 (4)

Loading locations...

相似试验